HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Streptococcal tonsillitis — Clinical Guidelines

Overview

Streptococcal tonsillitis, primarily caused by Group A β-hemolytic streptococci (GABHS), is a common infectious condition characterized by sore throat, fever, and often tonsillar exudates. Proper diagnosis and timely treatment are crucial to prevent complications and reduce recurrent infections 1 3 4.

Diagnosis

Clinical Criteria: Utilize Centor criteria for risk stratification 1.

Laboratory Tests: Consider C-reactive protein (CRP) tests and throat cultures for confirmation 1.

Microbiological Testing: Throat swab cultures are essential for definitive diagnosis 1 2.

Management

First-Line Treatment: Penicillin V 12.5 mg/kg twice daily for 10 days or amoxicillin 1 g twice daily for 6 days 6 13.

Alternative Antibiotics: Cefprozil or erythromycin base as effective alternatives 5 11.

Adjunctive Measures: Consider alpha-streptococci reimplantation for recurrent cases 8 9.

Special Populations

Children: Centor criteria and CRP tests recommended for guiding antibiotic use 1.

Adults: Similar antibiotic regimens as children, with consideration for individualized dosing based on serum concentrations 13.

Key Recommendations

Utilize Centor criteria and CRP tests for guiding antibiotic therapy in pediatric patients (Evidence: Moderate 1).

Prescribe penicillin V for 10 days or amoxicillin for 6 days as first-line treatments (Evidence: Moderate 6 13).

Consider reimplantation of alpha-streptococci in patients with recurrent streptococcal tonsillitis (Evidence: Weak 8 9).

Monitor for beta-lactamase-producing bacteria in treatment failures to guide alternative antibiotic choices (Evidence: Moderate 4 12 14).

References

1 Jääskeläinen J, Renko M, Kuitunen I. The impact of national guidelines on the diagnostics of sore throat in children. BMC pediatrics 2024. link 2 Bar-Yishay M, Yehoshua I, Bilitzky A, Press Y. Treatment outcomes of acute streptococcal tonsillitis according to antibiotic treatment. A retrospective analysis of 242,366 cases treated in the community. The European journal of general practice 2022. link 3 Mazur E, Czerwińska E, Grochowalska A, Kozioł-Montewka M. Concurrent peritonsillar abscess and poststreptococcal reactive arthritis complicating acute streptococcal tonsillitis in a young healthy adult: a case report. BMC infectious diseases 2015. link 4 Brook I. Failure of penicillin to eradicate group A beta-hemolytic streptococci tonsillitis: causes and management. The Journal of otolaryngology 2001. link 5 Brook I, Foote PA. Effect of penicillin or cefprozil therapy on tonsillar flora. The Journal of antimicrobial chemotherapy 1997. link 6 Peyramond D, Portier H, Geslin P, Cohen R. 6-day amoxicillin versus 10-day penicillin V for group A beta-haemolytic streptococcal acute tonsillitis in adults: a French multicentre, open-label, randomized study. The French Study Group Clamorange. Scandinavian journal of infectious diseases 1996. link 7 Roos K, Claesson R, Persson U, Odegaard K. The economic cost of a streptococcal tonsillitis episode. Scandinavian journal of primary health care 1995. link 8 Roos K, Holm SE, Grahn E, Lind L. Alpha-streptococci as supplementary treatment of recurrent streptococcal tonsillitis: a randomized placebo-controlled study. Scandinavian journal of infectious diseases 1993. link 9 Roos K, Grahn E, Holm SE, Johansson H, Lind L. Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. International journal of pediatric otorhinolaryngology 1993. link90047-7) 10 Caraco J, Arnon R, Raz I. Atrioventricular block complicating acute streptococcal tonsillitis. British heart journal 1988. link 11 Hovi T, Svahn T, Valtonen V. Twice-a-day regimen of erythromycin base is effective in the treatment of acute streptococcal tonsillitis. Scandinavian journal of infectious diseases 1987. link 12 Roos K, Grahn E, Holm SE. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scandinavian journal of infectious diseases 1986. link 13 Roos K, Holm SE, Ekedahl C. Treatment failure in acute streptococcal tonsillitis in children over the age of 10 and in adults. Scandinavian journal of infectious diseases 1985. link 14 Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Reviews of infectious diseases 1984. link 15 Holm SE, Grahn E. Bacterial interference in streptococcal tonsillitis. Scandinavian journal of infectious diseases. Supplementum 1983. link

Streptococcal tonsillitis